Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 56,912 shares at $60.50 ($3.5M) on 2020-04-06, disclosed to the SEC on 2020-04-08.
Seasonal sale ($3.5M) by Chairman — this insider has traded EBS in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.50 | 28,240 | $1.7M | 49.5% |
| 2 | $60.76 | 14,336 | $871K | 25.2% |
| 3 | $60.76 | 14,336 | $871K | 25.2% |
| Total | $60.63 avg | 56,912 | $3.5M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |